CAR T-cell Therapy in Multiple Myeloma: Finding Its Right Place - Episode 1
Optimizing CAR T in R/R MM: Treatment Paradigms and Patient Selection
Experts discuss where chimeric antigen receptor (CAR) T-cell therapy currently fits in the treatment paradigm, highlighting the patient factors and disease characteristics that influence its use in clinical decision-making.
Video Player is loading.
Video content above is prompted by the following:
Where does CAR T-cell therapy currently fall in your treatment paradigm? What type of patient factors and/or disease characteristics influence your approach?
